Changes in plasma concentration of immunoreactive (IR) 8-arginine vasopressin (AVP) during pregnancy and at delivery were examined by using a highly sensitive radioimmunoassay (RIA). The following results were obtained :
(1) The maternal plasma concentrations of IR-AVP decreased gradually during pregnancy and reached a plateau level after week 28 till delivery. From week 28, the plasma concentrations of IR -AVP were significantly lower than those before week 15 (2.4±0.36 pg/ml). Maternal plasma IR-AVP levels at normal vaginal delivery did not differ from those at delivery by elective cesarean section.
(2) The umbilical arterial plasma concentrations of IR-AVP at vaginal delivery (390±60.6 pg/ ml) which were significantly higher than those of umbilical venous plasma (224±34.1 pg/ml) were remarkably higher than at delivery by cesarean section (14.1±9.1 pg/ml).
(3) The fact that that the concentrations of IR-AVP in the umbilical arterial plasma at delivery in cases of asphyxia (505±74.1 pg/ml) were significantly higher than those at normal delivery (300± 13.3 pg/ml) is noteworthy.
These results suggest that :
(1) In mother, AVP acts as an antidiuretic hormone to maintain the homeostasis of physiologically increased total body water and decreased body tonicity associated with pregnancy.
(2) In fetus, AVP acts as a stress hormone to maintain the homeostasis of cardiovascular and metabolic systems which are subjected to the influence of labour.
View full abstract